Freedom Capital Markets Reiterates Buy Rating on ECVT

Freedom Capital Markets reiterated its buy rating on ECVT, maintaining a price target of $15. This announcement was made on June 29, 2026, reflecting continued confidence in the company's performance and prospects.

Other Institutional Activity in ECVT

Rubric Capital Management LP reduced its holdings in ECVT by 1,363,933 shares, bringing its total to 9,136,067 shares valued at approximately $117.5 million, marking a 13.0% decrease. BlackRock, Inc. also trimmed its position by 1,713,726 shares, ending with 8,734,220 shares worth about $112.3 million, a 16.4% reduction. Dimensional Fund Advisors LP slightly increased its stake by 111,376 shares to 6,498,654 shares valued at around $83.6 million, a 1.7% uptick. Hotchkis & Wiley Capital Management LLC significantly cut its position by 4,154,530 shares, leaving it with 5,413,862 shares valued at $69.6 million, a 43.4% decrease. Meanwhile, Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both initiated new positions, holding 5,244,406 and 4,977,580 shares respectively, valued at approximately $67.4 million and $64.0 million.

Ecovyst Inc. Stock Up 21.6%

On Monday, shares of ECVT were trading at $12.19. The stock has been experiencing activity from both institutional investors and insiders, reflecting varied confidence levels in its future performance.

Insider Buying and Selling at Ecovyst Inc.

Several insiders have been active in trading ECVT shares. Lorance Sarah sold 8,450 shares on June 2, 2026, at an average price of $13.33. On May 26, 2026, Patti Humble purchased 9,099 shares at $13.61. Earlier this year, on March 12, 2026, Kurt Bitting, Director and CEO, bought and sold 38,064 shares, with the purchase price at $3.04. Additionally, on March 4, 2026, Vice President and CFO Michael Feehan and Vice President Joseph Koscinski each bought 11,052 shares at $11.31.

Analysts Set New Price Targets

On June 29, 2026, both Freedom Capital Markets and Freedom Broker initiated coverage on ECVT with a buy rating and a $15 price target. Previously, on June 24, 2026, Citigroup maintained its hold rating with a $14.5 target. The consensus among analysts is generally favorable, with a buy recommendation and an average target price reflecting optimism about ECVT's potential.

Bottom Line

Freedom Capital Markets' reiterated buy rating with a $15 target highlights ongoing positive sentiment towards ECVT. The stock's activity, both from institutional investors and insiders, suggests varied but significant interest in its performance. As always, it's important to remember that such ratings are based on past data and should be considered in the broader context of market conditions.